KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Shares Outstanding (Weighted Average) (2016 - 2026)

Johnson & Johnson's Shares Outstanding (Weighted Average) history spans 18 years, with the latest figure at $2.4 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.06% to $2.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 billion, a 0.06% change, with the full-year FY2025 number at $2.4 billion, changed 0.0% from a year prior.
  • Shares Outstanding (Weighted Average) hit $2.4 billion in Q1 2026 for Johnson & Johnson, roughly flat from $2.4 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for JNJ hit a ceiling of $2.6 billion in Q1 2022 and a floor of $2.4 billion in Q2 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $2.5 billion across 5 years, with a median of $2.5 billion in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 7.57% in 2024 and later increased 0.06% in 2026.
  • Tracing JNJ's Shares Outstanding (Weighted Average) over 5 years: stood at $2.6 billion in 2022, then dropped by 3.59% to $2.5 billion in 2023, then fell by 4.98% to $2.4 billion in 2024, then grew by 0.0% to $2.4 billion in 2025, then grew by 0.05% to $2.4 billion in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for JNJ at $2.4 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.